Target intelligence / Profile preview

Thyroid size

Molecular classification
Other
01

Overview

Thyroid size refers to the physical volume and dimensions of the thyroid gland, serving as a critical clinical parameter and biomarker for thyroid health rather than a primary molecular target itself. In clinical practice, thyroid volume is typically measured via ultrasonography to assess for conditions such as goiter, nodules, or inflammatory changes associated with autoimmune thyroid diseases like Graves' disease and Hashimoto's thyroiditis (NIH StatPearls: Goiter). While thyroid size is not a receptor or enzyme, it is a primary clinical endpoint for therapies targeting the thyrotropin receptor (TSHR) or iodine metabolism pathways (PubMed: 28246348). Pharmacological interventions, such as Levothyroxine, aim to reduce thyroid size by suppressing the pituitary secretion of thyroid-stimulating hormone (TSH), thereby decreasing the trophic drive on thyroid follicular cells (PubMed: 11111626). Alternatively, antithyroid medications like Methimazole or the administration of radioactive iodine (I-131) are utilized to manage glandular enlargement associated with hyperthyroidism and toxic multinodular goiters (NIH: Thyroid Disease). Monitoring thyroid size is essential for evaluating the efficacy of endocrine treatments and for identifying potential compressive symptoms on adjacent anatomical structures like the trachea and esophagus.

Other names
Thyroid volumeThyroid gland dimensionsGoiter sizeThyroid enlargement
02

Mechanism of action

Reduction of thyroid size is achieved by suppressing pituitary thyroid-stimulating hormone (TSH) secretion via feedback inhibition or through the direct destruction of thyroid follicular cells via ionizing radiation or antithyroid medications.

03

Biological functions

Endocrine regulationTissue growth and homeostasisOrgan development
04

Disease associations

GoiterGraves' diseaseHashimoto's thyroiditisThyroid nodulesHyperthyroidismHypothyroidism
05

Safety considerations

Compression of the trachea or esophagusIatrogenic hypothyroidismThyroid storm during rapid reduction in hyperthyroid statesAirway obstruction due to substernal extension
06

Interacting drugs

Levothyroxine

5 more in the full profile.

07

Biomarkers

Thyroid ultrasound volumeThyroid-stimulating hormone (TSH) levelSerum thyroglobulin levelFree thyroxine (T4) level

Beyond the preview

Go deeper on Thyroid size.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyroid size.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call